Colgate-Palmolive Company

NYSE:CL Stock Report

Market Cap: US$71.6b

Colgate-Palmolive Future Growth

Future criteria checks 2/6

Colgate-Palmolive is forecast to grow earnings and revenue by 11.3% and 3.3% per annum respectively. EPS is expected to grow by 12.4% per annum. Return on equity is forecast to be 227.9% in 3 years.

Key information

11.3%

Earnings growth rate

12.37%

EPS growth rate

Household Products earnings growth4.9%
Revenue growth rate3.3%
Future return on equity227.91%
Analyst coverage

Good

Last updated12 Jun 2026

Recent future growth updates

Analysis Article • Aug 04

Colgate-Palmolive Company (NYSE:CL) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Shareholders might have noticed that Colgate-Palmolive Company ( NYSE:CL ) filed its quarterly result this time last...

Recent updates

Seeking Alpha • Jun 08

Colgate-Palmolive Q1: I Don't Think It Is Going To Outperform The Broader Index

Summary Colgate-Palmolive delivered solid Q1 results with 8.4% revenue growth and strong performance outside North America. CL’s North American segment continues to underperform, with a 28% decline in operating profit and ongoing margin pressure from tariffs and freight costs. The SGPP productivity program is being expanded, targeting $200m–$300m in annual pretax savings by 2028 through supply chain and operational optimizations. Despite robust cash generation and safe leverage, CL trades above 23x forward P/E, leading me to maintain a hold rating pending more impressive profitability improvements. Read the full article on Seeking Alpha
Narrative Update • Apr 09

CL: 2030 Plan Execution And Margins Will Shape 2026 Setup

Analysts have trimmed the Colgate-Palmolive fair value estimate by about $0.58 to $96.68, reflecting slightly softer revenue growth assumptions, a modestly lower future P/E, and mixed recent research that includes both reduced price targets and an upgrade tied to confidence in the 2030 plan and ongoing margin resilience. Analyst Commentary Recent Street research on Colgate-Palmolive shows a mix of optimism around the long-term plan and caution around nearer term cost and valuation risks.
Narrative Update • Mar 25

CL: 2030 Plan And Emerging Markets Execution Will Shape 2026 Setup

Colgate-Palmolive's fair value estimate edges up to $97.26 from $97.21 as analysts lift price targets toward the $100 to $105 range, citing stronger confidence in the 2030 plan, product innovation, and emerging markets execution. Analyst Commentary Recent Street research on Colgate-Palmolive clusters around higher price targets and upgraded ratings, with the fair value conversation increasingly framed around the 2030 plan, execution in emerging markets, and portfolio moves such as the exit from private label pet food.
Narrative Update • Mar 10

CL: 2030 Plan And Emerging Markets Support Measured 2026 Execution Setup

Analysts have nudged their price expectations for Colgate-Palmolive higher, with the updated fair value estimate moving from about $96.68 to roughly $97.21. They cite growing confidence in the company’s 2030 plan, product innovation efforts and emerging markets exposure, as reflected in a series of recent price target increases across major firms.
Narrative Update • Feb 24

CL: 2030 Plan And Emerging Markets Will Drive Balanced 2026 Setup

Analysts have raised their implied price target for Colgate-Palmolive by about $8 to reflect higher conviction in the company’s 2030 plan, product innovation pipeline and emerging market exposure, as well as refreshed views on sector valuations. Analyst Commentary Recent research has centered on how Colgate-Palmolive’s 2030 plan, product pipeline and emerging market footprint feed into both growth potential and current valuation.
Analysis Article • Feb 06

There May Be Some Bright Spots In Colgate-Palmolive's (NYSE:CL) Earnings

Colgate-Palmolive Company's ( NYSE:CL ) recent soft profit numbers didn't appear to worry shareholders, as the stock...
Narrative Update • Jan 28

CL: Emerging Markets And 2026 Setup Will Shape Balanced Risk Reward

Analysts have nudged their price targets for Colgate-Palmolive higher, reflected in a modest fair value move from about $87.47 to $88.89. They are factoring in slightly stronger revenue growth assumptions, a marginally higher future P/E and recent rating and target changes across firms such as Barclays, JPMorgan, UBS, Wells Fargo, Piper Sandler and TD Cowen.
Narrative Update • Jan 10

CL: Emerging Markets And 2026 Setup Support Balanced Outlook After Recent Softness

Our updated analyst price target for Colgate-Palmolive edges up to about US$87.47 from roughly US$87.21, as analysts balance slightly softer modeled revenue growth with modestly higher profit margin and future P/E assumptions. This view is supported by recent research that pairs cautious consumer staples outlooks with a more positive stance on the company’s emerging markets exposure and potential 2026 acceleration.
Narrative Update • Dec 15

CL: Emerging Market Strength Will Support Gradual Recovery As Q3 Softness Fades

Analysts have trimmed their price target on Colgate-Palmolive to $87 from the low-to-mid $90s, reflecting near term softness in Q3 results and muted personal care growth, even as they expect organic sales momentum to gradually improve. Analyst Commentary Analysts remain divided on Colgate-Palmolive, with recent target cuts reflecting near term execution risk, while longer term growth and margin recovery expectations stay largely intact.
Narrative Update • Nov 30

CL: Gradual Recovery Expected As Temporary Headwinds Ease In Personal Care Markets

Narrative Update on Colgate-Palmolive Colgate-Palmolive's analyst price target has been modestly reduced by $0.05 to $87.21. Analysts cite near-term growth challenges and muted sector outlooks following a soft Q3, but expect gradual improvement as temporary pressures ease.
Narrative Update • Nov 16

CL: Organic Sales Momentum Will Rebound As Near-Term Headwinds Ease

Colgate-Palmolive's analyst consensus price target was revised downward from approximately $88.84 to $87.26. Analysts cite a soft third quarter, moderated growth expectations, and ongoing category headwinds as key factors behind the adjustment.
Narrative Update • Nov 02

CL: Future Cost Optimization Will Drive Competitive Advantage Amid Category Headwinds

Colgate-Palmolive’s fair value estimate has been reduced from $90.74 to $88.84 per share. Analysts cite persistent category headwinds and a moderated sales outlook as factors behind lower price targets across the sector.
Narrative Update • Oct 18

Emerging Markets And Digital Transformation Will Unlock Global Value

Colgate-Palmolive's analyst fair value price target has decreased from $93.11 to $90.74. Analysts cite lowered sales guidance, persistent category headwinds, and muted growth outlooks as key factors behind their revised estimates.
Narrative Update • Oct 03

Emerging Markets And Digital Transformation Will Unlock Global Value

Colgate-Palmolive's analyst price target has been revised downward by approximately $2 to $93. Analysts cite ongoing category headwinds and decelerating growth in the personal care sector as reasons for this adjustment.
Analysis Article • Sep 30

There's Reason For Concern Over Colgate-Palmolive Company's (NYSE:CL) Price

Colgate-Palmolive Company's ( NYSE:CL ) price-to-earnings (or "P/E") ratio of 22.3x might make it look like a sell...
Analysis Article • Aug 04

Colgate-Palmolive Company (NYSE:CL) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Shareholders might have noticed that Colgate-Palmolive Company ( NYSE:CL ) filed its quarterly result this time last...
Analysis Article • Jun 27

Colgate-Palmolive (NYSE:CL) Has A Pretty Healthy Balance Sheet

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...
Seeking Alpha • Apr 22

A Historic Brand, A Fresh Approach: Inside Colgate-Palmolive's Machine

Summary Colgate-Palmolive achieved over $20 billion in revenue in 2024, driven by strong brand identity, operational discipline, and a diversified product portfolio across Oral Care, Personal Care, Home Care, and Pet Nutrition. The company maintained profitability despite inflation, with a 14.4% margin, and continued to invest in marketing and R&D, enhancing brand differentiation and price stability. Financially robust, Colgate-Palmolive showed significant revenue and margin growth, generating record free cash flow, and is well-positioned for 2025 with a "Buy" rating and a target share price of $100.08. Key risks include currency fluctuations, raw material costs, and competition, but strong daily demand for products and innovation in high-growth segments like Pet Nutrition support long-term growth. Read the full article on Seeking Alpha
Seeking Alpha • Mar 20

Colgate-Palmolive: A Defensive Stock With Growth Potential

Summary Colgate-Palmolive is one of the leaders in the global toothpaste market. On January 31, Colgate-Palmolive released financial results that left me with mixed reactions. Demand for its products in Latin America is growing rapidly, but the strengthening of the US dollar has not allowed Colgate-Palmolive to fully reflect this in its EPS. In this article, you, Seeking Alpha readers, will learn why, according to my "ALLKA 4D Rating" model, Colgate-Palmolive is a stock with an attractive risk/reward ratio. Read the full article on Seeking Alpha
Seeking Alpha • Mar 14

Is Colgate-Palmolive Quietly Building The Next Pet Food Empire?

Summary Colgate-Palmolive's premiumization strategy and pet nutrition expansion offer significant growth potential, with a price target of $115 per share, suggesting a 26% upside. Despite high valuation metrics, CL's superior profitability, high margins, and exceptional cash flow justify its premium valuation and long-term investment appeal. The company's strong pricing power, particularly in premium oral care and pet food, positions it well against inflation and competitive pressures. Risks include potential valuation compression and competition in pet nutrition, but CL's consistent cash flow and brand strength mitigate these concerns. Read the full article on Seeking Alpha
Seeking Alpha • Feb 25

Colgate-Palmolive: Don't Get Your Hopes Up (Yet)

Summary After a strong first half of 2024, Colgate-Palmolive's stock continues to be an underperformer in the consumer staples sector. The stock is trading at a discount to the level implied by current margins, but there is a good reason for that. Margins are likely to come under pressure in 2025 and from a dividend point of view, CL also appears unattractive at the moment. Read the full article on Seeking Alpha
Seeking Alpha • Jan 31

Colgate-Palmolive Stock: Post-Earnings Drop Isn't A Buy-The-Dip Moment

Summary Toothpaste and manual toothbrushes market leader Colgate-Palmolive Company released its fourth quarter and full-year 2024 results today. Judging by the share price reaction, and considering CL stock is down more than 20% from its all-time high, this clearly looks like a “buy the dip” moment. However, I'll explain why I don't think it's a good idea to buy CL shares, either for dividend or total return investors, and despite the company's undoubtedly solid 2024 performance. Read the full article on Seeking Alpha
Seeking Alpha • Dec 17

Colgate-Palmolive: Digital Advertising Is The Base From Which To Start Again

Summary Colgate-Palmolive's (CL) revenue growth has been minimal over the past decade, with a CAGR of only 1.53%, not even keeping pace with inflation. Despite a 61-year streak of increasing dividends, CL's EPS growth has been stagnant, leading to a higher payout ratio. Increased advertising expenditures, particularly in digital, have shown higher ROI than traditional channels. CL's future growth may hinge on digital advertising and expanding into Personal and Home Care markets, but the current valuation is too high for a buy rating. Read the full article on Seeking Alpha
Seeking Alpha • Dec 11

Colgate-Palmolive: Approaching Buy Territory With Some Important Catalysts

Summary As expected, Colgate-Palmolive's stock has retreated from its recent highs over the past few months. Upside potential for 2025 remains limited as gross margin tailwinds are fading. Nonetheless, there are some key areas that investors should keep a close eye on over the course of next year. Read the full article on Seeking Alpha
Seeking Alpha • Oct 25

Colgate-Palmolive Q3: Great Company, But Not Enough To Warrant A Position Now

Summary Colgate-Palmolive Company's Q3 earnings showed mixed results, with revenue and EPS beating estimates but North America and Latin America sales declining, leading to a 3% stock drop. The company's improved gross margins and increased advertising spend are positive signs, but the market remains concerned about regional sales declines. The Pet Nutrition segment shows strong growth potential, driven by the pet humanization trend, and could be a key revenue catalyst. Given macroeconomic uncertainties and regional performance, I rate Colgate-Palmolive stock as a hold, awaiting further developments in NA, LatAm, and Pet Nutrition segments. Read the full article on Seeking Alpha
Seeking Alpha • Oct 17

Colgate-Palmolive: Very Close To A Buy Following Recent Pullback

Summary Colgate-Palmolive is a high-quality business with consistent revenue growth, stable gross profit margins, and a strong return on invested capital, making it a solid dividend stock. The company has an impressive 61-year streak of consecutive dividend growth, maintaining a healthy payout ratio of around 60%, ensuring future dividend increases. The recent pace of dividend growth is below par but in line with inflation and top-line business growth. The recent pullback has brought the share price down very close to fair value. With earnings around the corner now may be a good time to consider jumping aboard. Colgate has beaten earnings estimates during the last 5 consecutive quarters, and recent analyst revisions indicate FQ3 may follow suit. Read the full article on Seeking Alpha
Seeking Alpha • Sep 30

Colgate-Palmolive: Share Price Returns Should Moderate (Rating Downgrade)

Summary Since I turned bullish on the stock, Colgate-Palmolive delivered a 36% total return in less than 10 months. For a consumer staples company the size of CL, returns will most likely moderate from here for two main reasons. As the impact of pricing initiatives fades away, investors should keep a close eye on volumes over the coming year. Read the full article on Seeking Alpha

Earnings and Revenue Growth Forecasts

NYSE:CL - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202822,9153,4673,7034,30412
12/31/202722,1553,1553,4073,94018
12/31/202621,4453,0042,7843,43218
3/31/202620,7952,0883,7674,345N/A
12/31/202520,3822,1323,6344,198N/A
9/30/202520,0972,9083,4434,014N/A
6/30/202519,9982,9083,3703,920N/A
3/31/202519,9472,8963,4674,026N/A
12/31/202420,1012,8893,5464,107N/A
9/30/202420,1062,8683,4003,974N/A
6/30/202419,9892,8403,3583,959N/A
3/31/202419,7522,6113,0233,691N/A
12/31/202319,4572,3003,0403,745N/A
9/30/202319,1361,5872,5533,282N/A
6/30/202318,6761,4972,3563,099N/A
3/31/202318,3381,5982,1682,905N/A
12/31/202217,9671,7851,8602,556N/A
9/30/202217,7411,9282,3212,989N/A
6/30/202217,7001,9442,3843,014N/A
3/31/202217,4762,0442,5313,113N/A
12/31/202117,4212,1662,7583,325N/A
9/30/202117,3422,6652,6473,182N/A
6/30/202117,0812,7292,6623,150N/A
3/31/202116,7182,6613,1143,549N/A
12/31/202016,4712,6953,3093,719N/A
9/30/202016,1622,6913,3683,726N/A
6/30/202015,9372,5713,3303,678N/A
3/31/202015,9062,5222,9503,296N/A
12/31/201915,6932,367N/A3,133N/A
9/30/201915,4892,330N/A3,025N/A
6/30/201915,4062,275N/A3,008N/A
3/31/201915,4262,326N/A3,045N/A
12/31/201815,5442,400N/A3,056N/A
9/30/201815,6252,117N/A2,953N/A
6/30/201815,7542,201N/A3,046N/A
3/31/201815,6942,088N/A2,979N/A
12/31/201715,4542,024N/A3,054N/A
9/30/201715,2832,307N/A3,119N/A
6/30/201715,1762,402N/A3,126N/A
3/31/201715,1952,478N/A3,218N/A
12/31/201615,1952,441N/A3,141N/A
9/30/201615,3732,461N/A3,158N/A
6/30/201615,5052,485N/A3,046N/A
3/31/201615,7262,459N/A2,836N/A
12/31/201516,0342,468N/A2,949N/A
9/30/201516,3562,470N/A3,014N/A
6/30/201516,7362,286N/A3,132N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: CL's forecast earnings growth (11.3% per year) is above the savings rate (3.5%).

Earnings vs Market: CL's earnings (11.3% per year) are forecast to grow slower than the US market (18.9% per year).

High Growth Earnings: CL's earnings are forecast to grow, but not significantly.

Revenue vs Market: CL's revenue (3.3% per year) is forecast to grow slower than the US market (13% per year).

High Growth Revenue: CL's revenue (3.3% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: CL's Return on Equity is forecast to be very high in 3 years time (227.9%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/22 05:47
End of Day Share Price 2026/06/18 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Colgate-Palmolive Company is covered by 42 analysts. 18 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Christopher GrajaArgus Research Company
Lauren LiebermanBarclays
Fulvio CazzolBerenberg